5 天
Vietnam Investment Review on MSNAIM Vaccine Cuts 2024 Losses by 90%, Paving the Way for Breakthrough GrowthAIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, ...
13 小时
The Punch on MSNPreventing infections in individuals with Sickle Cell DiseaseSickle Cell Disease is a genetic blood disorder that affects hemoglobin, causing red blood cells to become rigid and ...
DeZure. Which PCV vaccine your child gets will depend on what's available when they're immunized. There's also a pneumococcal ...
9 天
Pharmaceutical Technology on MSNEC approves MSD’s pneumococcal 21-valent conjugate CapvaxiveMSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...
Vaxcyte, Inc.'s stock fell 50% despite positive vaccine results. See how FDA uncertainty, competition, and Phase 3 delays ...
Discuss which vaccine is best for you with your doctor ... 19 through 49 years of age or older with certain risk conditions PPSV23 is the recommended type of vaccination for pneumococcal disease ...
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...
“The happiness index changes after a certain age,” said secretary Arup Sinha. For seniors, wellness is about staying engaged ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果